Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6380-08-1

Post Buying Request

6380-08-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6380-08-1 Usage

Description

N-(4-AMINOPHENYL)-4-METHYLBENZENESULFONAMIDE is an organic compound that serves as a key intermediate in the synthesis of various complex organic molecules, particularly in the preparation of imidazo[1,2-a]pyrazine derivatives.

Uses

Used in Pharmaceutical Industry:
N-(4-AMINOPHENYL)-4-METHYLBENZENESULFONAMIDE is used as a chemical intermediate for the synthesis of complex organic molecules, specifically imidazo[1,2-a]pyrazine derivatives, which have potential applications in the development of pharmaceutical compounds.
Used in Organic Synthesis:
N-(4-AMINOPHENYL)-4-METHYLBENZENESULFONAMIDE is used as a building block in the preparation of the following compounds:
1. 4-methyl-N-[4-[3-(2-naphthyl)imidazo[1,2-a]pyrazine-8-yl]aminophenyl]benzenesulfonamide
2. 4-methyl-N-[4-[2-(2-naphthyl)imidazo[1,2-a]pyrazine-8-yl]aminophenyl]benzenesulfonamide
3. 2and 3-substituted 8-amino imidazo[1,2-a]pyrazines
These synthesized compounds may exhibit various biological activities and properties, making them valuable for further research and potential applications in different fields.

Check Digit Verification of cas no

The CAS Registry Mumber 6380-08-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,8 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6380-08:
(6*6)+(5*3)+(4*8)+(3*0)+(2*0)+(1*8)=91
91 % 10 = 1
So 6380-08-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H14N2O2S/c1-10-2-8-13(9-3-10)18(16,17)15-12-6-4-11(14)5-7-12/h2-9,15H,14H2,1H3

6380-08-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (371777)  N-(4-Aminophenyl)-4-methylbenzenesulfonamide  99%

  • 6380-08-1

  • 371777-1G

  • 379.08CNY

  • Detail
  • Aldrich

  • (371777)  N-(4-Aminophenyl)-4-methylbenzenesulfonamide  99%

  • 6380-08-1

  • 371777-10G

  • 1,826.37CNY

  • Detail

6380-08-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-AMINOPHENYL)-4-METHYLBENZENESULFONAMIDE

1.2 Other means of identification

Product number -
Other names 4-p-toluenesulphonamido-aniline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6380-08-1 SDS

6380-08-1Relevant articles and documents

A Broad-Spectrum Catalytic Amidation of Sulfonyl Fluorides and Fluorosulfates**

Wei, Mingjie,Liang, Dacheng,Cao, Xiaohui,Luo, Wenjun,Ma, Guojian,Liu, Zeyuan,Li, Le

supporting information, p. 7397 - 7404 (2021/02/16)

A broad-spectrum, catalytic method has been developed for the synthesis of sulfonamides and sulfamates. With the activation by the combination of a catalytic amount of 1-hydroxybenzotriazole (HOBt) and silicon additives, amidations of sulfonyl fluorides and fluorosulfates proceeded smoothly and excellent yields were generally obtained (87–99 %). Noticeably, this protocol is particularly efficient for sterically hindered substrates. Catalyst loading is generally low and only 0.02 mol % of catalyst is required for the multidecagram-scale synthesis of an amantadine derivative. In addition, the potential of this method in medicinal chemistry has been demonstrated by the synthesis of the marketed drug Fedratinib via a key intermediate sulfonyl fluoride 13. Since a large number of amines are commercially available, this route provides a facile entry to access Fedratinib analogues for biological screening.

Method for preparing P-phenylenediamine from aniline

-

Paragraph 0075-0126, (2020/07/21)

The invention provides a method for preparing p-phenylenediamine from aniline. The method comprises the following steps: protecting amino on aniline by using p-toluenesulfonyl, mixing the aniline withan amino donor, an oxidant and a catalyst Ru-Cu/TS-1 to carry out ammoniation reaction, and performing separation after deprotection to obtain p-phenylenediamine. According to the invention, a protecting group strategy is adopted to protect amino on aniline by p-toluenesulfonyl, meanwhile, a C-H bond of a benzene ring para-position is induced and activated, and a catalyst Ru-Cu/TS-1 is adopted for catalyzing an ammoniation reaction, so that the ammoniation efficiency and selectivity can be greatly improved, and the yield and purity of p-phenylenediamine are improved. Moreover, the reaction conditions are mild, the selectivity is good, and the method is a green and environment-friendly synthesis route.

Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia

Liu, He,Qu, Menghua,Xu, Lina,Han, Xu,Wang, Changyuan,Shu, Xiaohong,Yao, Jihong,Liu, Kexin,Peng, Jinyong,Li, Yanxia,Ma, Xiaodong

, p. 60 - 69 (2017/04/24)

A new series of diphenylpyrimidine derivatives (SFA-DPPYs) were synthesized by introducing a functional sulfonamide into the C-2 aniline moiety of pyrimidine template, and then were biologically evaluated as potent Bruton's tyrosine kinase (BTK) inhibitors. Among these molecules, inhibitors 10c, 10i, 10j and 10k displayed high potency against the BTK enzyme, with IC50 values of 1.18?nM, 0.92?nM, 0.42?nM and 1.05?nM, respectively. In particular, compound 10c could remarkably inhibit the proliferation of the B lymphoma cell lines at concentrations of 6.49?μM (Ramos cells) and 13.2?μM (Raji cells), and was stronger than the novel agent spebrutinib. In addition, the inhibitory potency toward the normal PBMC cells showed that inhibitor 10c possesses low cell cytotoxicity. All these explorations indicated that molecule 10c could serve as a valuable inhibitor for B-cell lymphoblastic leukemia treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6380-08-1
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-571-87562588,87562561,87562573 Our Legal adviser: Lawyer